Results 141 to 150 of about 6,041 (204)

Assessment of Clonal Hematopoiesis of Indeterminate Potential from Cardiac Magnetic Resonance Imaging using Deep Learning in a Cardio-oncology Population

Background: We propose a novel method to identify who may likely have clonal hematopoiesis of indeterminate potential (CHIP), a condition characterized by the presence of somatic mutations in hematopoietic stem cells without detectable hematologic ...
Ahn, Shawn, Duncan, James S., Dvornek, Nicha C., Espinoza, Jeacy, Halene, Stephanie, Jha, Alokkumar, Kwan, Jennifer M, Ryu, Sangeon   +7 more
core  

CHIP (Clonal Hematopoiesis of Indeterminate Potential) [PDF]

Circulation, 2018
Peter, Libby, Benjamin L, Ebert
openaire   +2 more sources

Tissue-Equivalents of Lymphoid Clonal Hematopoiesis of Indeterminate Potential (L-CHIP) and Germline-Derived Lymphoproliferations: Possible Caveats for Hematopathologists. [PDF]

Hematol Oncol
Brune MM, Bratic Hench I, Dirnhofer S, Tzankov A.   +3 more
europepmc   +1 more source

Clonal hematopoiesis of indeterminate potential and the risk of cognitive impairment in the Women's Health Initiative Memory Study. [PDF]

Alzheimers Dement
Jakubek YA, Smith AP, Leng XI, Hall ME, Ezzat D, Pershad Y, Collins JM, Uddin MM, Fardo DW, Natarajan P, Bick AG, Kitzman JO, Honigberg MC, Hayden KM, Manson JE, Jaiswal S, Whitsel EA, Reiner AP.   +17 more
europepmc   +1 more source

Managing Cardiovascular Risk in Clonal Hematopoiesis of Indeterminate Potential: JACC: CardioOncology Short-Form Primer. [PDF]

JACC CardioOncol
Oren O, Small AM, Lin AE, Libby P.
europepmc   +1 more source

Clonal hematopoiesis of indeterminate potential as a risk factor for atrial fibrillation: Evidence of a causal relationship by Mendelian randomization study. [PDF]

Heart Rhythm O2
Zhang Q, Wang G, Yan Z, Xu W, Zhang S, Li J, Liang L, Sun C, Tang R, Pircher J, Xie Q, Zheng W.   +11 more
europepmc   +1 more source

Clonal Hematopoiesis Risk Score (CHRS) Evaluation as a Prognostic Marker for Death in Cardio-Oncology Cohort

JACC: Advances
Jaiveer Singh, MS, Rachel Jaber Chehayeb, MD, Yunju Im, PhD, Irvin Yi, BA, Talal El Zarif, MD, Ana Ferrigno Guajardo, MD, Jennifer VanOudenhove, PhD, Stephanie Halene, MD, Alok Jha, PhD, Jennifer M. Kwan, MD, PhD   +9 more
doaj   +1 more source

Clonal hematopoiesis of indeterminate potential (CHIP) and risk of non-Hodgkin lymphoma: A community-based cohort study. [PDF]

Hemasphere
Liu M, Zhou L, Liu Q, Wang X, Wei H, Liu Q.   +5 more
europepmc   +1 more source

Letter to the Editor: Clonal hematopoiesis of indeterminate potential and the risk of breast cancer: a UK Biobank cohort study. [PDF]

Int J Surg
Yang A, Pan J.
europepmc   +1 more source

Clonal hematopoiesis of indeterminate potential and kidney disease

Clonal hematopoiesis of indeterminate potential (CHIP) is an acquired hematologic disorder that affects more than 10% of individuals aged 65 and older. Individuals with CHIP have acquired mutations in myeloid cancer-associated genes such as DNMT3A and TET2 in their hematopoietic stem cells (HSCs).
openaire   +1 more source